Developing An In Vitro Model Of A Human Blastocyst
Funder
National Health and Medical Research Council
Funding Amount
$890,062.00
Summary
Using novel cellular and molecular technologies we propose to develop an artificial model of an early human blastocyst. This will allow us to study the first initial steps in human development without the use of real embryos. Such a model will not only help us decipher the first steps in human development, but we anticipate it will be essential to study how gene mutations and the environment affect this initial step in human development.
Vaccine To Prevent Influenza Virus And Bacterial Super-infection.
Funder
National Health and Medical Research Council
Funding Amount
$707,717.00
Summary
Influenza viruses have the ability to pre-dispose infected hosts toward secondary bacterial complications. The mortality of viral infections that are complicated by a concurrent, or subsequent, bacterial infection (known as a super-infection), is often greater than that of either the virus or the bacteria alone. We will develop a novel multi-pathogen vaccine candidate against the major upper respiratory tract pathogens - Influenza A and Streptococcus pyogenes to prevent super-infections.
Growth Factor Directed Developmental And Pathological Lymphangiogenesis
Funder
National Health and Medical Research Council
Funding Amount
$1,048,507.00
Summary
The formation of new lymphatic vessels occurs in normal development and in diseased tissues in cancer and cardiovascular disease. We have developed an understanding of how lymphatics form in development but we understand far less about how they form in disease. This project will apply multidisciplinary approaches, including genetics and computational biology, to compare how lymphatics form in development and disease. We hope to uncover new ways to manipulate this process for therapeutic gain.
Harnessing Information Technology To Improve Self-management Behaviours And Health Outcome In People With Heart Failure: A Smarthome Ecosystem Living Lab Study
Funder
National Health and Medical Research Council
Funding Amount
$1,120,226.00
Summary
The burden of heart failure in Australia is substantial. Management of heart failure is complex and requires self-management of symptoms and behaviour change, which requires ongoing education and support to achieve. Current approaches for supporting self-management do not meet the needs of people with heart failure or the healthcare system. This Australian first project aims to co-design an intelligent smart home ecosystem (Smart Heart) to support the management for people with heart failure.
Relaxin Receptor Structural Determination To Aid Therapeutic Development
Funder
National Health and Medical Research Council
Funding Amount
$1,249,114.00
Summary
The receptor for the peptide hormone relaxin, RXFP1, is being targeted by numerous drug companies for the treatment of cardiovascular disease. However, the lack of molecular detail of how relaxin binds and activates RXFP1 is hindering new drug development. We will determine the structure of the complex of relaxin bound to RXFP1 and the mechanism by which this activates cells. The knowledge gained will aid in the design of new drugs targeting RXFP1 for the treatment of cardiovascular disease.
Harnessing The Benefits Of Autonomous Vehicles For Health
Funder
National Health and Medical Research Council
Funding Amount
$738,596.00
Summary
The arrival of autonomous vehicles (AVs) will have huge implications for health behaviours, including physical activity and diet. It is critical that appropriate planning processes are undertaken as early as possible to prevent cities of the future being designed around AVs rather than people, thereby losing the potential for this new technology to be harnessed as a means of enhancing health. This project will facilitate the inclusion of health considerations in AV implementation processes.
Elucidating The Role Of Transthalamic Pathways In Cortical Processing
Funder
National Health and Medical Research Council
Funding Amount
$792,688.00
Summary
Your brain senses the world and produces a suitable motor response by processing information between brain regions, such as primary sensory cortex to secondary cortex. Surprisingly, cortical pathways have a parallel route through the thalamus (transthalamic pathways) but their function is entirely unknown. We will use novel genetic and viral tools to shut down neural pathways while mice make decisions, thus identifying new circuits in our understanding of disorders with cognitive deficits.
Reprogramming Human Fibroblasts Into Induced Trophoblast Stem Cells
Funder
National Health and Medical Research Council
Funding Amount
$889,064.00
Summary
We have been able to generate artificial human trophectoderm which is the tissue that creates the placenta. This will allow us to do research in how the genes control the fate of these cells without the need of human embryos or placenta. We anticipate that the derivation and characterising these cells will revolutionise placenta research, which in turn will contribute to the establishment of new therapies for placenta disease and infertility.
Neonatal Therapy For Improving Myelination And Long Term Outcome Following Preterm Birth
Funder
National Health and Medical Research Council
Funding Amount
$799,883.00
Summary
Preterm birth leads to the early loss of the nurturing uterine environment which supports key developmental processes. This results in behavioural disorders later in life including attention deficit hyperactivity disorder and anxiety. Preterm birth leads to loss of support for the maturation of oligodendrocyte cells and myelination which contributes to these disorders. This work will delineate therapies for preterm neonates that restore myelination and improve long-term behavioural outcomes.
Identifying The Optimal Age To Apply Physical Activity Interventions To Improve Heart Health
Funder
National Health and Medical Research Council
Funding Amount
$852,804.00
Summary
By performing sophisticated, novel and sensitive measurements on the heart at age 30 and linking these to richly characterised historical data, we will determine whether there is an optimal age to apply physical activity interventions to improve adult heart health. This is possible using data collected from 18 weeks pregnancy through to adulthood in ~3,000 Australians. This study will inform policy and interventions to reduce heart disease; the single biggest cause of mortality in Australia.